Lipid-loaded tumor-associated macrophages sustain tumor growth and invasiveness in prostate cancer.
Masetti M
J Exp Med. 2021 Dec 17;219(2)doi: 10.1084/jem.20210564
Lipid-loaded macrophages as new therapeutic target in cancer.
Marelli G
J Immunother Cancer. 10(7)doi: 10.1136/jitc-2022-004584
Macrophages and bone metastasis.
Di Mitri D, Conforti F, Mantovani A
J Exp Med. 2023 Feb 24;220(4)doi: 10.1084/jem.20222188
Loss-of-function mutations in APOC3, triglycerides, and coronary disease.
Crosby J
N Engl J Med. 2014 Jun 18;371(1):22-31. doi: 10.1056/NEJMoa1307095
Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis.
Paraboschi EM
Hum Mol Genet. 2014 Jul 30;23(25):6746-61. doi: 10.1093/hmg/ddu392
Glucocerebrosidase mutations in primary parkinsonism.
Asselta R
Parkinsonism Relat Disord. 2014 Sep 9;20(11):1215-20. doi: 10.1016/j.parkreldis.2014.09.003
Inactivating mutations in NPC1L1 and protection from coronary heart disease.
Stitziel NO
N Engl J Med. 2014 Nov 12;371(22):2072-82. doi: 10.1056/NEJMoa1405386
Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction.
Do R
Nature. 2014 Dec 10;518(7537):102-6. doi: 10.1038/nature13917
Hepatic fibrinogen storage disease: identification of two novel mutations (p.Asp316Asn, fibrinogen Pisa and p.Gly366Ser, fibrinogen Beograd) impacting on the fibrinogen γ-module.
Asselta R
J Thromb Haemost. 2015 Jul 14;13(8):1459-67. doi: 10.1111/jth.13021
miR-634 is a Pol III-dependent intronic microRNA regulating alternative-polyadenylated isoforms of its host gene PRKCA.
Paraboschi EM
Biochim Biophys Acta Gen Subj. 2017 Feb 14;1861(5 Pt A):1046-1056. doi: 10.1016/j.bbagen.2017.02.016